This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 1997-1998.
Company Filing History:
Years Active: 1997-1998
Title: The Innovations of Daniel Smith
Introduction
Daniel Smith is a notable inventor based in Hamden, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of retinoid-like compounds. With a total of 2 patents to his name, Smith's work has the potential to impact medical treatments significantly.
Latest Patents
Smith's latest patents include innovative compounds that exhibit retinoid-like activity. The first patent focuses on RAR.gamma.-specific retinobenzoic acid derivatives. These compounds selectively interact with the retinoic acid subtype RAR.gamma. and have been found to lack the liver toxicity associated with systemic administration of non-relative retinoids. The second patent also involves RAR.gamma.-specific retinobenzoic acid derivatives, showcasing similar properties and potential therapeutic benefits.
Career Highlights
Daniel Smith is currently employed at Bristol-Myers Squibb Company, where he continues to advance his research in pharmaceuticals. His work is characterized by a commitment to developing safer and more effective treatments for patients.
Collaborations
Some of his notable coworkers include R Thomas Swann and Kenneth M Tramposch, who contribute to the collaborative environment at Bristol-Myers Squibb.
Conclusion
Daniel Smith's innovative work in the field of pharmaceuticals highlights his dedication to improving medical treatments through his patented inventions. His contributions are paving the way for advancements in retinoid-like compounds that could benefit many patients in the future.